EMA review of sleeping sickness treatment requested by Sanofi

Sanofi has requested a review by the European Medicines Agency (EMA) of its treatment for sleeping sickness, fexinidazole, which it is developing in collaboration with the Drugs for Neglected Disease initiative (DNDi). Read more

31 Jan 2018 12:35 News